MyAverix Finance
US · Healthcare
Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
Biotechnology
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $1.18B, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for COAG
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) — FAQ
What is Hemab Therapeutics Holdings, Inc. Common Stock's market cap?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has a reported market cap of $1.18B (data as of 2026-05-22).
What is COAG's P/E ratio?
The price-to-earnings (P/E) ratio for Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is 25.00 (data as of 2026-05-22).
Does Hemab Therapeutics Holdings, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Hemab Therapeutics Holdings, Inc. Common Stock (COAG). Check the MyAverix Finance app for the latest dividend data.
What sector is Hemab Therapeutics Holdings, Inc. Common Stock in?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is classified in the Healthcare sector (Biotechnology industry).
What exchange is COAG listed on?
COAG is listed on US.
What is Hemab Therapeutics Holdings, Inc. Common Stock's net margin?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.